Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist?
about
Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A ReviewOutcomes and prognostic factors of patients with stage IB and IIA pancreatic cancer according to the 8th edition American Joint Committee on Cancer criteria.Trajectory of care and use of multimodality therapy in older patients with pancreatic adenocarcinoma.Current and emerging therapies for the treatment of pancreatic cancer.RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy.Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging.Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor.Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of DiseaseNeoadjuvant chemoradiation in patients with pancreatic adenocarcinoma.Combined endoscopic and laparoscopic ultrasound as preoperative assessment of patients with pancreatic cancer.Original Scientific Reports: Clinicopathological Findings of Remnant Pancreatic Cancers in Survivors Following Curative Resections of Pancreatic Cancers.Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma.Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and from patient-matched metastatic sitesCurrent surgical aspects of palliative treatment for unresectable pancreatic cancer.Current state of surgical management of pancreatic cancer.Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death.Outcomes following resection of pancreatic adenocarcinoma: 20-year experience at a single institution.Definition of microscopic tumor clearance (r0) in pancreatic cancer resections.Anti-tumor activity of erlotinib in the BxPC-3 pancreatic cancer cell line.Intraoperative radiation therapy (IORT) in pancreatic cancer.Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63.Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death.A new option for treatment of postoperative pancraticojejunal anstomosis leakage in pancraticoduodenectomy: Easy and safe.Identification of HLA-A2-restricted CTL epitopes of a novel tumour-associated antigen, KIF20A, overexpressed in pancreatic cancer.Pancreaticobiliary Drainage by T-tube, A promising Technique for Prevention of Pancreatic Leakage following Pancreaticoduodenectomy (Whipple Surgery).Pressurized Intra Peritoneal Aerosol Chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma.Pancreatic cancer in the remnant pancreas following primary pancreatic resection.Proteomic identification of potential prognostic biomarkers in resectable pancreatic ductal adenocarcinoma.Using circulating tumor cells to evaluate the efficacy of irreversible electroporation for unresectasble pancreatic cancer.Surgery for recurrent pancreatic ductal adenocarcinoma
P2860
Q26765288-BD4ADA94-9D7B-44E7-8518-926F7B831CF2Q33599558-08E9A0EA-374F-43EF-B089-578539606F4AQ33905392-26E41DB3-231D-4671-A7C0-6F87F5E9CA38Q34129346-5958EB5D-27AB-4EF7-AE34-40F2BB518E92Q34165809-B3CA4B28-30B6-4999-B27A-C6DE1CD30D42Q34591102-8EB66263-4868-4A12-8039-8AE70D074FDFQ34890924-BF751B36-5C4A-48E8-8FC5-EF5C3D70CCA4Q35871175-9306BF9D-353F-4BD4-A5AB-FC7FF7FA04F6Q36253159-BD0E8270-7FA4-4BC6-851D-F9384EA6FE58Q36253175-C92EA61D-E0FB-4845-8DB3-212A1F84CBC1Q36620479-A2FC4CE0-48CE-43E4-BB31-3C023730CBB0Q36747372-2B33FCC7-0EBE-4FEF-AD87-2A2960568AA5Q37086209-365E00AE-836D-4F84-89B4-79770D2A6882Q37129811-DD448D0C-158D-442E-880F-81E6560FD195Q37129872-4D9751C9-381D-430F-832D-1B84118E15B1Q37167523-6C4AD950-CF7E-475C-8B9D-4518E36FB6ADQ37277964-8DCD4153-A536-4585-8438-F7D9169504C4Q37342765-D1EF8207-59BB-43B7-AC27-24BF3EA01628Q37347275-C642382B-47F6-4219-93C8-0633EAD0F63FQ37576549-861C096B-5B54-4E9A-8849-7702900952CEQ37687744-E68EADC1-FCD0-4B6D-80B3-67A58302AAA6Q38827698-BF31FBF7-8418-481F-BBC2-4CF1738E5FD5Q40830806-793B5731-648A-4342-98C2-1CC46D36698FQ42108269-96765C80-E3C9-463E-9B15-DC745CD9BAE6Q42113077-3FBFFF97-A876-43E9-B917-131C90512169Q44424534-C7CD90D7-561D-4A84-BB68-68DA9475FE0DQ44894591-CF1F2EB0-6F29-4DEB-A5C9-E42E2A515385Q46296450-DBD69497-9C46-4DAC-A88B-F38DD929946FQ48295235-7E3D8434-DD82-4779-8763-EA58BBBC314AQ57767733-E1D06941-59AF-4EAB-88B0-6A9A1CAD3461
P2860
Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist?
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Survival after surgical manage ...... d radical surgery truly exist?
@ast
Survival after surgical manage ...... d radical surgery truly exist?
@en
type
label
Survival after surgical manage ...... d radical surgery truly exist?
@ast
Survival after surgical manage ...... d radical surgery truly exist?
@en
prefLabel
Survival after surgical manage ...... d radical surgery truly exist?
@ast
Survival after surgical manage ...... d radical surgery truly exist?
@en
P2093
P2860
P1476
Survival after surgical manage ...... d radical surgery truly exist?
@en
P2093
C H J van Eijck
H G Smeenk
T C K Tran
P2860
P2888
P304
P356
10.1007/S00423-004-0476-9
P407
P577
2004-05-14T00:00:00Z